Lisa Townsend1, Kenneth Kobak2, Catherine Kearney3, Michael Milham4, Charissa Andreotti5, Jasmine Escalera5, Lindsay Alexander5, Mary Kay Gill6, Boris Birmaher6, Raeanne Sylvester6, Dawn Rice6, Alison Deep2, Joan Kaufman7. 1. Kennedy Krieger Institute, Baltimore, MD; Johns Hopkins School of Medicine, Baltimore, MD. 2. Center for Telepsychology, Madison, WI. 3. Kennedy Krieger Institute, Baltimore, MD. 4. Child Mind Institute, New York, NY; Nathan Kline Institute, Orangeburg, NY. 5. Child Mind Institute, New York, NY. 6. Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, PA. 7. Kennedy Krieger Institute, Baltimore, MD; Johns Hopkins School of Medicine, Baltimore, MD. Electronic address: joan.kaufman@kennedykrieger.org.
Abstract
OBJECTIVE: To present initial validity data on three web-based computerized versions of the Kiddie Schedule for Affective Disorders and Schizophrenia (KSADS-COMP). METHOD: The sample for evaluating the validity of the clinician-administered KSADS-COMP included 511 youths 6-18 years of age who were participants in the Child Mind Institute Healthy Brain Network. The sample for evaluating the parent and youth self-administered versions of the KSADS-COMP included 158 youths 11-17 years of age recruited from three academic institutions. RESULTS: Average administration time for completing the combined parent and youth clinician-administered KSADS-COMP was less time than previously reported for completing the paper-and-pencil K-SADS with only one informant (91.9 ± 50.1 minutes). Average administration times for the youth and parent self-administered KSADS-COMP were 50.9 ± 28.0 minutes and 63.2 ± 38.3 minutes, respectively, and youths and parents rated their experience using the web-based self-administered KSADS-COMP versions very positively. Diagnoses generated with all three KSADS-COMP versions demonstrated good convergent validity against established clinical rating scales and dimensional diagnostic-specific ratings derived from the KSADS-COMP. When parent and youth self-administered KSADS-COMP data were integrated, good to excellent concordance was also achieved between diagnoses derived using the self-administered and clinician-administered KSADS-COMP versions (area under the curve = 0.89-1.00). CONCLUSION: The three versions of the KSADS-COMP demonstrate promising psychometric properties, while offering efficiency in administration and scoring. The clinician-administered KSADS-COMP shows utility not only for research, but also for implementation in clinical practice, with self-report preinterview ratings that streamline administration. The self-administered KSADS-COMP versions have numerous potential research and clinical applications, including in large-scale epidemiological studies, in schools, in emergency departments, and in telehealth to address the critical shortage of child and adolescent mental health specialists. CLINICAL TRIAL REGISTRATION INFORMATION: Computerized Screening for Comorbidity in Adolescents With Substance or Psychiatric Disorders; https://clinicaltrials.gov/; NCT01866956.
OBJECTIVE: To present initial validity data on three web-based computerized versions of the Kiddie Schedule for Affective Disorders and Schizophrenia (KSADS-COMP). METHOD: The sample for evaluating the validity of the clinician-administered KSADS-COMP included 511 youths 6-18 years of age who were participants in the Child Mind Institute Healthy Brain Network. The sample for evaluating the parent and youth self-administered versions of the KSADS-COMP included 158 youths 11-17 years of age recruited from three academic institutions. RESULTS: Average administration time for completing the combined parent and youth clinician-administered KSADS-COMP was less time than previously reported for completing the paper-and-pencil K-SADS with only one informant (91.9 ± 50.1 minutes). Average administration times for the youth and parent self-administered KSADS-COMP were 50.9 ± 28.0 minutes and 63.2 ± 38.3 minutes, respectively, and youths and parents rated their experience using the web-based self-administered KSADS-COMP versions very positively. Diagnoses generated with all three KSADS-COMP versions demonstrated good convergent validity against established clinical rating scales and dimensional diagnostic-specific ratings derived from the KSADS-COMP. When parent and youth self-administered KSADS-COMP data were integrated, good to excellent concordance was also achieved between diagnoses derived using the self-administered and clinician-administered KSADS-COMP versions (area under the curve = 0.89-1.00). CONCLUSION: The three versions of the KSADS-COMP demonstrate promising psychometric properties, while offering efficiency in administration and scoring. The clinician-administered KSADS-COMP shows utility not only for research, but also for implementation in clinical practice, with self-report preinterview ratings that streamline administration. The self-administered KSADS-COMP versions have numerous potential research and clinical applications, including in large-scale epidemiological studies, in schools, in emergency departments, and in telehealth to address the critical shortage of child and adolescent mental health specialists. CLINICAL TRIAL REGISTRATION INFORMATION: Computerized Screening for Comorbidity in Adolescents With Substance or Psychiatric Disorders; https://clinicaltrials.gov/; NCT01866956.
Authors: Danielle C DeVille; Diana Whalen; Florence J Breslin; Amanda S Morris; Sahib S Khalsa; Martin P Paulus; Deanna M Barch Journal: JAMA Netw Open Date: 2020-02-05
Authors: Bradley S Peterson; Amy E West; John R Weisz; Wendy J Mack; Michele D Kipke; Robert L Findling; Brian S Mittman; Ravi Bansal; Steven Piantadosi; Glenn Takata; Corinna Koebnick; Ceth Ashen; Christopher Snowdy; Marie Poulsen; Bhavana Kumar Arora; Courtney M Allem; Marisa Perez; Stephanie N Marcy; Bradley O Hudson; Stephanie H Chan; Robin Weersing Journal: BMC Psychiatry Date: 2021-06-30 Impact factor: 3.630
Authors: Bradley R Grant; Kerry O'Loughlin; Hannah M Holbrook; Robert R Althoff; Catherine Kearney; Francheska Perepletchikova; Damion J Grasso; James J Hudziak; Joan Kaufman Journal: Int Rev Psychiatry Date: 2019-12-27
Authors: Joseph O'Neill; Mary J O'Connor; Guldamla Kalender; Ronald Ly; Andrea Ng; Andrea Dillon; Katherine L Narr; Sandra K Loo; Jeffry R Alger; Jennifer G Levitt Journal: Brain Imaging Behav Date: 2021-06-05 Impact factor: 3.978
Authors: Laika D Aguinaldo; Aimee Goldstone; Brant P Hasler; David A Brent; Clarisa Coronado; Joanna Jacobus Journal: Psychiatry Res Date: 2021-02-23 Impact factor: 3.222
Authors: Ashley L Watts; Phillip K Wood; Kristina M Jackson; Krista M Lisdahl; Mary M Heitzeg; Raul Gonzalez; Susan F Tapert; Deanna M Barch; Kenneth J Sher Journal: Dev Psychopathol Date: 2021-10
Authors: Alexandra S Potter; Max M Owens; Matthew Albaugh; Hugh Garavan; Kenneth J Sher; Joan Kaufman; Deanna M Barch Journal: J Am Acad Child Adolesc Psychiatry Date: 2020-08-12 Impact factor: 8.829